Clinical Trial

The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2023 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This study was designed to compare the effects on atrial rhythm control between SGLT2 inhibitor and other oral hypoglycemic agents in patients with atrial fibrillation and diabetes mellitus. We are to compare efficacy and safety between these two groups.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-08-29.
Status change: Not Yet Recruiting → Enrolling by Invitation 2023-01-19
Trial Details
NCT Number NCT05029115
Lead Sponsor Ewha Womans University Mokdong Hospital
Conditions SGLT-2 Inhibitor, Atrial Fibrillation, Diabetes Mellitus, Type 2
Enrollment 716 participants
Start Date 2021-10-05
Primary Completion 2025-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2023-01-23